- Home
- FICO vs MIST Comparison
FICO vs MIST Comparison
Compare FICO & MIST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | FICO | MIST |
|---|---|---|
| Founded | 1956 | 2003 |
| Country | United States | Canada |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 41.2B | 163.2M |
| IPO Year | 1987 | N/A |
Fundamental Metrics
Financial Performance| Metric | FICO | MIST |
|---|---|---|
| Price | $1,717.55 | $2.00 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 12 | 4 |
| Target Price | ★ $1,999.83 | $8.50 |
| AVG Volume (30 Days) | 194.9K | ★ 9.8M |
| Earning Date | 02-03-2026 | 11-12-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 29.78 | N/A |
| EPS | ★ 26.54 | N/A |
| Revenue | ★ $1,990,869,000.00 | N/A |
| Revenue This Year | $24.77 | N/A |
| Revenue Next Year | $17.55 | N/A |
| P/E Ratio | $65.66 | ★ N/A |
| Revenue Growth | ★ 15.91 | N/A |
| 52 Week Low | $1,300.00 | $0.63 |
| 52 Week High | $2,217.60 | $3.06 |
Technical Indicators
Market Signals| Indicator | FICO | MIST |
|---|---|---|
| Relative Strength Index (RSI) | 44.38 | 37.35 |
| Support Level | $1,726.39 | $2.00 |
| Resistance Level | $1,767.90 | $2.22 |
| Average True Range (ATR) | 46.64 | 0.32 |
| MACD | -11.64 | -0.09 |
| Stochastic Oscillator | 4.40 | 25.86 |
Price Performance
Historical ComparisonAbout FICO Fair Isaac Corproation
Founded in 1956, Fair Isaac Corporation is a leading applied analytics company. Fair Isaac is primarily known for its FICO credit scores, which is a widely used industry benchmark to determine the creditworthiness of an individual consumer. The firm's US-centric credit scores business accounts for most of the firm's revenue and profits and consists of business-to-business and business-to-consumer services. In addition to scores, Fair Isaac also sells software primarily to financial institutions for areas such as analytics, decision-making, customer workflows, and fraud.
About MIST Milestone Pharmaceuticals Inc.
Milestone Pharmaceuticals Inc is a biopharmaceutical company dedicated to developing and commercializing etripamil for the treatment of cardiovascular medicines. Etripamil is a calcium channel blocker developed as a rapid-onset nasal spray to be administered by the patient to treat episodes of paroxysmal supraventricular tachycardia, or PSVT. The company has an ongoing Phase 2 clinical trial for patients with atrial fibrillation experiencing a rapid ventricular rate (AFib-RVR).